Big Gain For ImmunoGen, Inc.
Tue, Nov 30, 2021 at 05:30 PM
ImmunoGen, Inc. (IMGN:NASDAQ) shot up at $6.17, a gain of 29.9%. On Mon, Nov 29, 2021, IMGN:NASDAQ touched a New 2-Week Low of $4.75. The stock got featured on our News Catalysts scanner on Tue, Nov 30, 2021 at 03:34 PM in the 'BIOTECH' category. From Mon, Nov 15, 2021, the stock recorded 11.11% Up Days and 30.00% Green Days
About ImmunoGen, Inc. (IMGN:NASDAQ)
Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
Top 10 Gainers:
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 128.64%
- iFresh Inc. (IFMK:NASDAQ), 50%
- VOSO (VOSO:NASDAQ), 43.95%
- MEI Pharma, Inc. (MEIP:NASDAQ), 37.55%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 32.5%
- Ardelyx, Inc. (ARDX:NASDAQ), 32.24%
- ImmunoGen, Inc. (IMGN:NASDAQ), 29.89%
- Gritstone Oncology, Inc. (GRTS:NASDAQ), 25.71%
- CLNN (CLNN:NASDAQ), 22.37%
- GBS (GBS:NASDAQ), 22.22%